Full Press Release Details
Scientific Announces
Third Quarter Sales and Earnings
| Exchange: NASDAQ (KEQU) | Contact: D. Michael Parker |
| 704/871-3290 |
NC, February 26, 2009-Kewaunee Scientific Corporation (NASDAQ: KEQU) today
announced results for its third quarter ended January 31, 2009.
earnings for the quarter increased to $882,000, or $0.35 per diluted share, up
10% from $802,000, or $0.31 per diluted share, in the same period last year.
Earnings benefited from the higher sales volume, solid operational performances
throughout the Company, and the stabilization of costs for key raw materials and
energy. Net earnings for the nine months ended January 31, 2009 were $3,327,000,
or $1.30 per diluted share, up 24% from net earnings of $2,688,000, or $1.05 per
diluted share, in the same period last year.
the quarter were $26,023,000, up 19% over sales of $21,883,000 in the same
period last year. Sales benefited from continuing higher levels of new orders
and the record order backlog. Sales for the nine months ended January
31, 2009 were $79,150,000, up 17% from sales of $67,394,000 in the same period
from domestic operations during the quarter were $22,498,000, up 27% from the
same period last year. Domestic sales for the nine months ended January 31, 2009
were $67,296,000, an increase of 21% from the same period last year. Sales from
international operations were $3,525,000, down 17% from the same period last
year. The decline resulted primarily from a softer Singapore laboratory
furniture market. International sales for the nine months ended January 31, 2009
were $11,854,000, up 2% from the same period last year.
backlog at January 31, 2009 was $60.7 million, up from $58.8 million at January
31, 2008, and down slightly from $61.6 million at the end of the previous
quarter. The domestic marketplace for laboratory furniture products
provided an extremely high number of opportunities during the quarter, and the
Company had one of the strongest quarters of quotation activity in its history.
Although some slowing of activity in the Asian laboratory marketplace was noted
during the quarter, the Company closed two significant orders in Asia that added
to the order backlog.
Company's financial condition continues to be strong. Bank borrowings and
capital lease obligations were $6,318,000 at January 31, 2009, up from
$4,243,000 at January 31, 2008, with the increase primarily the result of
receivables associated with the increase in sales. Cash on hand was $3,089,000,
as compared to $2,882,000 at the end of the same period last year. Working
capital was $17,749,000 at the end of the quarter, up from $14,671,000 at the
end of the same period last year.
pleased with the Company's strong performance during the third quarter," said
William A. Shumaker, President and Chief Executive Officer. "Our
strategic efforts over the past several years to make Kewaunee a more efficient
Company are working well. We have not yet noticed any significant
impact from the global economic slowdown on our business or opportunities in the
domestic laboratory furniture marketplace, but we remain keenly aware of this
serious situation. We are diligently pursuing a number of
strategies that will help position the Company in case of an economic downturn
in our industry and, at the same time, make the Company even stronger when the
believe the Company is on track for a good fourth quarter. Sales
should benefit from our strong order backlog, and earnings should benefit from
lower costs for some of our key raw materials and our on-going cost reduction
activities. We expect aggressive competitive pricing will continue, and probably
accelerate, in the coming months."
Company also announced today that its Board of Directors approved a cash
dividend of eight cents per outstanding share to stockholders of record at the
close of business on March 12, 2009, payable on March 26, 2009.
Scientific Corporation is a recognized leader in the design, manufacture, and
installation of scientific and technical furniture. The Company's corporate
headquarters and domestic manufacturing facilities are located in Statesville,
North Carolina. The Company has subsidiaries in Singapore and
Bangalore, India that serve the Asian and Middle East
markets. Kewaunee Scientific's website is located at
statements in this release constitute "forward-looking" statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors that could significantly impact results or achievements expressed
or implied by such forward-looking statements. These factors include, but are
not limited to, economic, competitive, governmental, and technological factors
affecting the Company's operations, markets, products, services, and
Statements of Operations
thousands, except per share data)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| January 31 | January 31 | |||||||||||||||
| 2009 | 2008 | 2009 | 2008 | |||||||||||||
| Net sales | $ | 26,023 | $ | 21,883 | $ | 79,150 | $ | 67,394 | ||||||||
| Cost of products sold | 21,089 | 17,064 | 62,846 | 52,759 | ||||||||||||
| Gross profit | 4,934 | 4,819 | 16,304 | 14,635 | ||||||||||||
| Operating expenses | 3,440 | 3,293 | 10,884 | 9,811 | ||||||||||||
| Operating earnings | 1,494 | 1,526 | 5,420 | 4,824 | ||||||||||||
| Other income (expense) | 3 | (6 | ) | (36 | ) | (2 | ) | |||||||||
| Interest expense | (49 | ) | (86 | ) | (231 | ) | (302 | ) | ||||||||
| Earnings before income taxes | 1,448 | 1,434 | 5,153 | 4,520 | ||||||||||||
| Income tax expense | 488 | 421 | 1,595 | 1,391 | ||||||||||||
| Earnings before minority interests | 960 | 1,013 | 3,558 | 3,129 | ||||||||||||
| Minority interests | 78 | 211 | 231 | 441 | ||||||||||||
| Net earnings | $ | 882 | $ | 802 | $ | 3,327 | $ | 2,688 | ||||||||
| Net earnings per share | ||||||||||||||||
| Basic | $ | 0.35 | $ | 0.32 | $ | 1.30 | $ | 1.07 | ||||||||
| Diluted | $ | 0.35 | $ | 0.31 | $ | 1.30 | $ | 1.05 | ||||||||
| Weighted average number of common shares outstanding (in thousands) | ||||||||||||||||
| Basic | 2,556 | 2,543 | 2,554 | 2,523 | ||||||||||||
| Diluted | 2,556 | 2,576 | 2,563 | 2,551 |
Consolidated Balance Sheets
| January 31 | April 30 | |||||||
| 2009 | 2008 | |||||||
| (unaudited) | ||||||||
| Assets | ||||||||
| Cash and cash equivalents | $ | 2,691 | $ | 3,784 | ||||
| Restricted cash | 398 | 480 | ||||||
| Receivables, less allowances | 24,723 | 20,087 | ||||||
| Inventories | 7,678 | 6,984 | ||||||
| Prepaid expenses and other current assets | 1,359 | 1,847 | ||||||
| Total current assets | 36,849 | 33,182 | ||||||
| Net property, plant and equipment | 11,601 | 11,825 | ||||||
| Other assets | 5,064 | 5,599 | ||||||
| Total Assets | $ | 53,514 | $ | 50,606 | ||||
| Liabilities and Stockholders' Equity | ||||||||
| Short-term borrowings | $ | 5,815 | $ | 4,551 | ||||
| Current obligations under capital leases | 268 | 323 | ||||||
| Accounts payable | 8,211 | 8,929 | ||||||
| Other current liabilities | 4,806 | 3,459 | ||||||
| Total current liabilities | 19,100 | 17,262 | ||||||
| Other non-current liabilities | 5,295 | 6,397 | ||||||
| Total stockholders' equity | 29,119 | 26,947 | ||||||
| Total Liabilities and Stockholders' Equity | $ | 53,514 | $ | 50,606 |